Claire Verschraegen, MD

The James Cancer Center
Claire Verschraegen

Clinical Expertise

  • Gynecologic Cancers
  • Medical Oncology
  • Melanoma
  • Mesothelioma
  • Sarcoma
Insurance Information

Gender

Female

I am a professor of medicine and director of the Division of Medical Oncology in the Department of Internal Medicine at The Ohio State University College of Medicine. I also hold the Diane Nye and Michael Rayden Chair in Innovative Cancer Research at Ohio State and serve as associate director for translational research at Ohio State's Comprehensive Cancer Center.

I am a board-certified medical oncologist who specializes in treating patients with rare cancers, including mesothelioma, metastatic melanoma, sarcomas and gynecologic malignancies. Another of my specialties is the study of new anticancer drugs and treatments for solid tumors. My work has been continuously funded for more than 20 years, including grant support for phase I, II and III clinical trials. I have been appointed by the National Cancer Institute (NCI) to serve on many committees, such as the NCI Gynecological Cancer Steering Committee, which approves the federally-sponsored randomized studies for gynecological cancers.

I was recruited to Ohio State in 2017 from the University of Vermont, where I was a professor of medicine, director of Hematology/Oncology, director of the cancer service line and co-director of the University of Vermont Cancer Center. I earned my master's degree and medical degree at the Université Libre de Bruxelles in Belgium and trained at the Institut Jules Bordet in internal medicine/oncology. I then completed a cancer research fellowship at the Stehlin Foundation for Cancer Research and an internal medicine residency training at the University of Houston, followed by a medical oncology fellowship at The University of Texas MD Anderson Cancer Center.

In my 30 years as an academic medical oncologist, much progress has been made in treating some cancers through novel targeted therapies and immunotherapies, a result of the well-planned clinical and translational studies to which I have devoted the greatest part of my professional life. I am privileged to continue this mission at the OSUCCC - James, with which I share a vision of creating a cancer-free world.


Education and Background

Education

  • Universite Libre De Bruxelles

    B-1000 Brussels, Belgium

Fellowship

  • Hematology/Oncology

    MD Anderson Cancer Center

    Houston, TX

  • Research

    Christus Stehlin Foundation for Cancer Research

    Houston, 77025

  • Internal Medicine

    Universite Libre De Bruxelles

    B-1000 Brussels, Belgium

Board Certifications

  • American Board of Internal Medicine
  • American Board of Internal Medicine (Subspecialty: Medicine Oncology)

Academic Department

I see patients at

The James at Martha Morehouse Medical Plaza

2050 Kenny Road, Columbus, Ohio 43221

614-293-3885

The James Cancer Hospital and Solove Research Institute

460 West 10th Avenue, Columbus, Ohio 43210

800-293-5066


Consulting and Related Relationships

At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the university requires annual disclosures from all faculty members with external interests related to their university responsibilities. As of 3/26/2018, Dr. Verschraegen has reported no relationships with companies or entities.


Publications

Back to Find a Doctor Search

Make an Appointment

800-293-5066

Please enter a keyword (i.e. Name, Cancer Type) or choose a Principle Investigator

OR

Please enter a keyword (i.e. Name, Location) or choose a Cancer Type

OR